Location: Barcelona, SpainJob reference: R-208204Date posted: 09/03/2024Location: Barcelona, Spain (on-site) 3 days working from the office and 2 days working from homeThe Director, Global Health Economics and Outcomes Research (GHEOR) leads the strategic development and execution of health economics and outcomes research strategies to support the worldwide launch and reimbursement of products across a range of disease areas. This particular role would lead the Real World Evidence and Patient Reported Outcomes as a Center of Excellence to promote capabilities within the Rare Disease portfolio to bring leadership, efficiency and impact to patients with rare disease.Through key leadership and partnership across cross-functional teams, the job holder enables RWE and PRO strategy to be embedded into broader disease area and clinical development strategies via the therapeutic area leaders. This collaboration builds strategies to demonstrate and differentiate the value proposition and corresponding scientific evidence of Alexion products for payers, patients, clinical institutions, and other key influencers. The Director, Global HEOR partners with and provides leadership to HEOR/Medical, Market Access, Clinical Development, and Commercial teams as well as regions and countries. This role reports directly to the Senior Director EUCAN & International Head HEOR.You will be responsible for:Utilizing in-depth knowledge of disease area and portfolio strategy in combination with health economics and outcomes research to develop and build capabilities for RWE and PRO. Ensuring patient and stakeholder relevant endpoints and evidence generation strategies are implemented throughout the product lifecycle.Building collaborative relationships with cross-functional leaders across Medical, Research & Development, Commercial, and Market Access organizations to maximize evidence generation efforts to optimize launch and sustained reimbursement throughout the product lifecycle.Partnering with the Therapeutic Area (TA) heads and Regional/Country teams to develop TA business strategies and clinical development plans that will provide a competitive advantage to differentiated patient relevant evidence; driving efficient and innovative HEOR study development and study execution and dissemination.Continually monitoring the global marketplace for market access issues, identifying access/demand hurdles, and creating plans to demonstrate the value and differentiation of assets within the therapeutic area portfolio.Ensuring Alexion maintains external credibility and relationships to validate research findings and communications.Cultivating and maintaining relationships with key experts, influencers, and customer segments to foster and maintain Alexion's credibility to support the value and reimbursement of Alexion products.Delivering presentations on behalf of Alexion at various industry and scientific forums and/or contributing to publications.Maintaining the relationship with external agencies and monitoring their performance to ensure that performance and deliverables meet business expectations.Contributing to the global HEOR infrastructure to provide direction and guidance to Regional HEOR and Country Medical teams.Developing best practices in HEOR including approaches to areas including research methodologies, study designs, endpoints that provide scientifically sound protocols, policies, tools, and outcome impact.Providing global oversight and guidance to country teams to adapt the global strategies into tactical plans through robust Health Technology Assessment processes to achieve optimal access and sustained reimbursement throughout the product lifecycle.Identifying areas for process improvements, economies of scale, and other quality and efficiency measures.You will need to have:PhD or equivalent combination of education and experience.10+ years prior experience in HEOR, RWE or Epidemiology in the biopharmaceutical/pharmaceutical industry.Thorough understanding of the field of Health Technology Assessment at a global level and experience of successful negotiations through the HTA processes.Extensive experience in RWE, both prospective and retrospective observational research.Expertise in PRO development, assessment, validation and providing guidance on inclusion of PRO instruments in clinical trials.Understanding of the global market access landscape and environment.Knowledge of the drug development and commercialization process.Recognized as a strong leader with a proven track record of effectively managing, influencing, and developing people including those who are not direct reports; demonstrated ability to lead and deliver results in a matrix environment, and solve complex issues that cross multiple stakeholders.Excellent interpersonal skills with a track record of effectiveness as a team player; excellent oral/written communication, and presentation skills.Excellent project leadership skills.
#J-18808-Ljbffr
